- Home
- DNLI vs BL Comparison
DNLI vs BL Comparison
Compare DNLI & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- BL
- Stock Information
- Founded
- DNLI 2013
- BL 2001
- Country
- DNLI United States
- BL United States
- Employees
- DNLI N/A
- BL N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- BL Computer Software: Prepackaged Software
- Sector
- DNLI Health Care
- BL Technology
- Exchange
- DNLI Nasdaq
- BL Nasdaq
- Market Cap
- DNLI 3.3B
- BL 3.7B
- IPO Year
- DNLI 2017
- BL 2016
- Fundamental
- Price
- DNLI $20.84
- BL $60.33
- Analyst Decision
- DNLI Strong Buy
- BL Hold
- Analyst Count
- DNLI 11
- BL 12
- Target Price
- DNLI $40.40
- BL $66.00
- AVG Volume (30 Days)
- DNLI 867.7K
- BL 503.1K
- Earning Date
- DNLI 02-25-2025
- BL 02-11-2025
- Dividend Yield
- DNLI N/A
- BL N/A
- EPS Growth
- DNLI N/A
- BL 45.65
- EPS
- DNLI N/A
- BL 0.98
- Revenue
- DNLI N/A
- BL $639,606,000.00
- Revenue This Year
- DNLI N/A
- BL $13.81
- Revenue Next Year
- DNLI $420.35
- BL $9.02
- P/E Ratio
- DNLI N/A
- BL $61.60
- Revenue Growth
- DNLI 204.74
- BL 11.39
- 52 Week Low
- DNLI $14.56
- BL $43.37
- 52 Week High
- DNLI $33.33
- BL $69.31
- Technical
- Relative Strength Index (RSI)
- DNLI 35.14
- BL 42.17
- Support Level
- DNLI $19.93
- BL $59.55
- Resistance Level
- DNLI $21.64
- BL $62.63
- Average True Range (ATR)
- DNLI 0.96
- BL 1.71
- MACD
- DNLI -0.06
- BL -0.57
- Stochastic Oscillator
- DNLI 21.56
- BL 14.13
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About BL BlackLine Inc.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their financial close process including account reconciliations, variance analysis of account balances, journal entry capabilities, and certain types of data matching capabilities. The majority of the revenue of the company is earned in the United States.